Overview

• The study is the first global patient trial of field cycling imaging, a low-field MRI technique developed at the University of Aberdeen 50 years after the first MRI was invented there
• Scottish Government funding of £350,000 supports scans of glioblastoma patients receiving chemotherapy after surgery and chemoradiotherapy
• Field cycling imaging can operate at low and ultra-low magnetic fields to extract detailed tissue information that conventional MRI cannot provide
• Researchers hope FCI will distinguish between genuine tumour growth and ‘pseudo-progression’, reducing unnecessary treatment changes and patient anxiety
• Glioblastoma is the UK’s most aggressive brain tumour with over 3,000 new cases annually and a median survival of 15 months, and enhanced imaging could speed evaluation of emerging therapies